Skip to main content
. Author manuscript; available in PMC: 2016 Nov 20.
Published in final edited form as: Stat Med. 2015 Jun 21;34(26):3424–3443. doi: 10.1002/sim.6558

Table 4.

Linear regression for the effects of stage-1 treatments on the potential final outcome if their corresponding optimal stage-2 treatments had been received

Estimate SE p-value
Intercept 1.248 0.1004 < 0.001
Age −0.0109 0.0053 0.039
KA/VE vs. CVD 0.2366 0.1286 0.066
TEC vs. CVD 0.2757 0.1294 0.033
TEE vs. CVD 0.0475 0.1370 0.729